Coordinated response cuts time to treatment for deadly heart attacks

August 01, 2016

DALLAS, Aug. 1, 2016 -- When emergency medical services (EMS) and hospital providers worked together in a coordinated system, people suffering deadly heart attacks received life-saving treatment sooner, according to a new study in the American Heart Association's journal Circulation.

Often considered the most deadly type of heart attack, ST segment elevation myocardial infarction, or STEMI, happens when the blood supply to the heart is completely blocked. Quickly opening the blocked artery can restore normal blood flow, minimize heart damage and save lives.

National guidelines recommend the blockage be opened and blood flow restored within 90 minutes of the patient's first contact with emergency medical personnel for patients taken straight to a hospital that performs percutaneous coronary interventions (PCI). The goal is within 120 minutes for patients transferred from hospitals that do not perform PCI to those that do.

The American Heart Association Mission: Lifeline STEMI Systems Accelerator demonstration project created regional care systems aimed at increasing the number of people treated within the guideline recommendations. Carried out between July 2012 and December 2013, it is the largest effort to organize regional STEMI care ever attempted in the U.S. The demonstration, involved 484 hospitals and 1,253 EMS agencies in 16 regions in the country, treating 23,809 patients presenting with STEMI. There were 11,765 patients transported by EMS and 6,502 self-transported directly to PCI-capable hospitals, while 5,542 patients transferred from another facility.

During the time of the demonstration project, there was a modest, but significant increase in the proportion of patients meeting the guideline goals: Among the 16 regions involved in the project, the five with greatest improvement increased the proportion of patients treated within guideline goals from 45 percent to 57 percent, with one region treating 75 percent within goal by the end of the project. Improvements among regions varied and overall increases were modest, in part, because some regions were slower than others to incorporate protocols and systematic changes within the relatively short time window of the intervention, Jollis said.

Historically, of the more than 250,000 people who have a STEMI each year, up to half are not treated within the recommended time.

The problem is a lack of coordination among those who care for STEMI patients before and after they get to the hospital, as well as diverse treatment plans among the 15,000 EMS agencies and 5,200 acute care hospitals in the U.S., said James G. Jollis, M.D., a study author and clinical professor of medicine at the University of North Carolina in Chapel Hill.

"Ideally, paramedics using a 12-lead EKG can recognize if an artery is blocked, diagnose STEMI in the field and route patients straight to specialized hospitals as they notify the hospital to activate the heart catheterization team immediately," Jollis said.

"This project shows it is possible to coordinate emergency cardiovascular systems and transform care in some of the largest U.S. cities, including New York, Houston and Atlanta," said Christopher B. Granger, M.D., study co-author and professor of medicine at Duke University in Durham, N.C. "This coordinated care between EMS and hospitals shortens emergency department times and correlates with lower mortality."

"In line with the fullest implementation of the project, we began to observe trends toward lower in-hospital mortality compared with national data toward the end of our measurement period," Jollis said. "The long-term goal is to have this protocol in place for every STEMI patient who suffers a heart attack in the community. Ultimately, death from heart attack should become a rare event."
Other authors are Hussein R. Al-Khalidi, Ph.D.; Mayme L. Roettig, R.N., M.S.N.; Peter B. Berger, M.D.; Claire C. Corbett, M.M.S.; Harold L. Dauerman, M.D.; Christopher B. Fordyce, M.D.; Kathleen Fox, R.N., B.S.; J. Lee Garvey, M.D.; Tammy Gregory; Timothy D. Henry, M.D.; Ivan C. Rokos, M.D.; Matthew W. Sherwood, M.D., M.H.S.; Robert E. Suter, D.O.; and B. Hadley Wilson, M.D.

Author disclosures are on the manuscript.

The Regional Systems of Care Demonstration Project: Mission: Lifeline STEMI Systems Accelerator is supported by the ACTION Registry-Get With The Guidelines and education and research grants by The Medicines Company, Abiomed, Inc, Philips Healthcare, and AstraZeneca.

Additional Resources:

Heart images and emergency response photos and videos are located in the right column of this release link

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at

American Heart Association

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to